[144] Enova International, Inc. SEC Filing

Rhea-AI Filing Summary

Enova International (ENVA) Form 144 notice shows an intended sale of 6,000 common shares through Merrill Lynch (Chicago) with an aggregate market value of $750,000 and an approximate sale date of 09/19/2025. The filer reports those shares were acquired on 02/12/2019 via stock option from Enova International. The filing also lists multiple sales by David Fisher over the past three months, totaling 88,000 shares across seven transactions, with gross proceeds reported for each sale. The notice is procedural under Rule 144 and serves to disclose proposed insider sales and recent insider transactions.

Positive

• Compliance disclosure filed under Rule 144 showing transparency about proposed insider sale
• Acquisition method disclosed (stock option dated 02/12/2019), clarifying the insider's basis for the shares

Negative

• Substantial recent insider selling: 88,000 shares sold in the past three months by David Fisher across multiple transactions
• Planned additional sale of 6,000 shares valued at $750,000 could add near-term selling pressure

Insights

Securities Analyst

TL;DR: Insider plans to sell 6,000 shares and has completed sizable recent sales; disclosure is routine but increases supply pressure.

The filing documents a proposed Rule 144 sale of 6,000 common shares valued at $750,000 and details sizable prior sales by the same insider totaling 88,000 shares in the past three months, with material gross proceeds per trade. From a market-impact perspective, clustered insider sales can increase available float and may be viewed negatively by some investors. The Form 144 itself confirms compliance with Rule 144 disclosure requirements but does not explain intent or provide forward-looking context.

Corporate Governance Expert

TL;DR: Multiple large insider disposals warrant governance scrutiny though the filing is a standard compliance disclosure.

The record shows repeated sales by David Fisher and a new proposed sale tied to a stock option grant from 2019. This pattern raises governance questions about insider liquidity needs and timing, but the Form 144 provides only transactional facts without commentary on trading plans or 10b5-1 arrangements. Investors should note the disclosure but recognize it supplies no evidence of undisclosed company issues.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 110 N Wacker Dr, Ste 1900 Chicago IL 60606	6000	750000	25012613	09/19/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/12/2019	Stock Option	Enova International			6000	02/12/2019	Stock Option

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David Fisher 175 West Jackson Blvd, Ste 600 Chicago IL 60604	Common	06/20/2025	2000	196762.87
David Fisher 175 West Jackson Blvd, Ste 600 Chicago IL 60604	Common	07/14/2025	5000	575951.66
David Fisher 175 West Jackson Blvd, Ste 600 Chicago IL 60604	Common	08/26/2025	5000	588801.44
David Fisher 175 West Jackson Blvd, Ste 600 Chicago IL 60604	Common	08/28/2025	15000	1826442.6
David Fisher 175 West Jackson Blvd, Ste 600 Chicago IL 60604	Common	08/29/2025	10000	1217589.22
David Fisher 175 West Jackson Blvd, Ste 600 Chicago IL 60604	Common	09/04/2025	20000	2438319.06
David Fisher 175 West Jackson Blvd, Ste 600 Chicago IL 60604	Common	09/17/2025	35000	4392807

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Enova International (ENVA) Form 144 disclose?

The Form 144 discloses a proposed sale of 6,000 common shares (aggregate value $750,000) and multiple recent insider sales totaling 88,000 shares.

Who is reported as selling ENVA shares in this filing?

The filing lists a proposed sale tied to an insider who acquired shares via a stock option on 02/12/2019 and records recent sales by David Fisher at a Chicago address.

When is the approximate date for the proposed sale of ENVA shares?

The approximate date listed for the proposed sale of 6,000 shares is 09/19/2025.

How much did recent insider sales for ENVA generate?

The filing reports gross proceeds for each sale; cumulative recent gross proceeds are listed per transaction (examples include $2,438,319.06 for 20,000 shares on 09/04/2025).

Does this Form 144 indicate a 10b5-1 plan adoption?

The filing includes the standard representation language but does not specify any date of plan adoption or explicit 10b5-1 instruction in the remarks section.